BIOTRONIK - SaFety and Performance Registry for an All-comers Patient Population With the Limus Eluting Orsiro Stent System Within Daily Clinical Practice - III Belgium
Phase of Trial: Phase IV
Latest Information Update: 05 Oct 2017
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery disease; Myocardial infarction; Thrombosis; Venous thromboembolism
- Focus Therapeutic Use
- Acronyms BIOFLOW-III
- Sponsors BIOTRONIK
- 26 Sep 2017 Status changed from active, no longer recruiting to completed.
- 11 Apr 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Jul 2016 as reported by ClinicalTrials.gov record.
- 08 Sep 2015 Planned primary completion date changed from 1 Aug 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov.